Health News (Reuters)

Drug charity halts patient aid after U.S. health agency pulls approval

BOSTON (Reuters) - One of the largest patient assistance charities in the United States said it will not provide financial aid in 2018 after the government revoked its approval to do so because of concerns that drugmakers had improper influence over the charity.

Hungary's Richter expects Esmya drug ruling in first half: CEO

BUDAPEST (Reuters) - Hungarian drugmaker Richter expects European health inspectors to deliver a ruling on its Esmya medicine in the first half of 2018, its chief executive told Reuters, adding that uncertainty about the drug could delay earnings guidance.

Can living near a gym make you slimmer?

(Reuters Health) - People who live close to gyms, pools and playing fields weigh less and have smaller waistlines than their counterparts residing farther away from exercise facilities, a UK study suggests.

FDA expands use of Amgen's blockbuster drug

(Reuters) - Amgen Inc said on Friday that the U.S. Food and Drug Administration approved its drug, Xgeva, to prevent fractures in patients with multiple myeloma.

Future of Kala Pharma's dry eye drug uncertain after mixed results

(Reuters) - Mixed results from two late-stage studies testing Kala Pharmaceuticals Inc's drug to provide temporary relief from dry eye disease cast doubt on the drug's path forward and sent shares down 16 percent in early trading on Friday.

Trump administration drops Obama-era easing of marijuana prosecutions

WASHINGTON (Reuters) - The U.S. Justice Department on Thursday rescinded an Obama administration policy that had eased enforcement of federal marijuana laws in states that legalized the drug, instead giving federal prosecutors wide latitude to pursue criminal charges.

Use of non-cigarette tobacco products tied to teen smoking

(Reuters Health) - - Teens who try e-cigarettes, hookah pipes and other non-cigarette tobacco products are more likely to take up cigarette smoking than their peers who never sample these products, a U.S. study suggests.

Trump administration rescinds Obama-era marijuana enforcement policy

WASHINGTON (Reuters) - The U.S. Justice Department on Thursday rescinded an Obama administration policy that had eased enforcement of federal marijuana laws in states that legalized the drug, instead giving federal prosecutors wide latitude on pursuing criminal charges.

Neurontin prescriptions surge amid opioid crisis

(Reuters Health) - - Prescriptions for nerve pain medicines like Neurontin and Lyrica have more than tripled in recent years, driven by increased use among chronically ill older adults and patients already taking opioids, a U.S. study suggests.

Trump administration rule would let more Americans drop Obamacare

WASHINGTON (Reuters) - The Trump administration on Thursday proposed a rule to allow Americans who are self-employed or work for small businesses to buy health insurance that does not comply with all Obamacare requirements in an effort to unwind the 2010 healthcare law.

CMS to cover Abbott's glucose monitoring device

(Reuters) - Abbott Laboratories said on Thursday its newly launched glucose monitoring device would be covered by the Centers for Medicare & Medicaid Services, expanding its usage to millions of diabetes patients in the United States.

Suspected diphtheria cases in Yemen near 500: WHO

GENEVA (Reuters) - At least 471 people in Yemen are believed to have been infected with diphtheria, killing one in 10 of them since the outbreak began in mid-August, the World Health Organization (WHO) said on Thursday.

Philippines fines Sanofi, suspends clearance for Dengvaxia

MANILA (Reuters) - The Philippines has suspended clearance for Sanofi's dengue vaccine Dengvaxia and fined the French drugmaker a symbolic $2,000 citing violations on product registration and marketing, the health secretary said on Thursday.

Pages